Auto Amazon Links: No products found. Blocked by captcha.
Health Reporter Philippa Roxby has reported that some patients taking the weight-loss drug Mounjaro are facing difficulties in obtaining the medicine, leading to concerns about the impact on their health. This issue has arisen due to an increase in demand for the drug after US manufacturer Eli Lilly announced a significant price hike from 1 September. The company has cautioned against stockpiling of medicines and has requested UK distributors to cease taking orders from pharmacies by the end of the day.
Patients like Lynne Massey-Davis, a 65-year-old from East Yorkshire, have shared their struggles in finding Mounjaro stock, with reports of delayed deliveries and scarcity of the medication. Lynne, who has seen positive results with a reduced BMI and improved health since starting the drug, expressed worries about the current situation but remains committed to staying safe. The National Pharmacy Association (NPA) has acknowledged the surge in demand for Mounjaro ahead of the price increase, impacting the drug’s supply in the short term.
Providers like Chemist4U have noted limited supplies of Mounjaro, prioritizing existing patients in need of dose adjustments. CEO James O’Loan anticipates a return to normal supply levels after Eli Lilly releases new stock post-September 1. Pharmacist Sehar Shahid advises against panic bulk-buying, highlighting the importance of medical supervision when considering alternative weight-loss medications. Marie Cook, a patient prescribed Mounjaro for type 2 diabetes, highlighted the urgency of the situation as she faces dwindling supplies of the drug essential for her health.
Eli Lilly has reassured patients about allocations in place for pharmacies and providers following the regulatory guidelines to prevent inappropriate stockpiling of medicines. The company emphasized the importance of ordering medication according to the current treatment plan to minimize disruption and ensure optimal patient care. As the situation unfolds, patients are urged to seek guidance from healthcare professionals and refrain from making hasty decisions based on social media influences
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.